Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-07-04 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a company announcement detailing specific transactions related to Novozymes' share buyback program (aktietilbagekøbsprogram). It lists the number of shares purchased, the average price, and the total transaction value, explicitly referencing the 'Safe Harbour Regulation'. This falls directly under the definition of a company reporting on the buyback or sale of its own shares.
2016-07-04 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement detailing the company's ongoing stock buyback program, specifically listing the number of shares purchased, average prices, and transaction values over a specific period. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2016-07-04 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program' and provides a table summarizing the number of shares purchased and the transaction value over several days (June 20 to June 24, 2016). This directly relates to the company repurchasing its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a specific report detailing these transactions, not just an announcement of a report.
2016-06-27 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text is very short (255 characters) and explicitly states that Novozymes has bought back a specific number of shares under a previously announced share repurchase program ('aktietilbagekøbsprogram'). This directly relates to the company buying back its own shares. The final line, 'Læs hele meddelelsen i PDF' (Read the full announcement in PDF), suggests this is a brief notification rather than the full detailed report. The most specific category for reporting the company buying back its own shares is 'Transaction in Own Shares' (POS).
2016-06-27 Danish
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document provides specific details on shares repurchased under the company’s own stock buyback programme (number of shares, transaction value, programme reference). This fits the definition of a Transaction in Own Shares report rather than a simple announcement of publication or another category.
2016-06-27 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement detailing specific transactions related to Novozymes' share buyback program (aktietilbagekøbsprogram). It provides a table of daily share purchases, average prices, and total transaction values, which is characteristic of a 'Transaction in Own Shares' filing. It explicitly mentions the 'Safe Harbour Regulation' and updates the total number of treasury shares held by the company.
2016-06-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.